Fast Market Research

New Market Study, "Galapagos NV - Product Pipeline Review - 2013", Has Been Published

New Pharmaceuticals market report from Global Markets Direct: "Galapagos NV - Product Pipeline Review - 2013"


Boston, MA -- (SBWIRE) -- 02/05/2014 -- Global Market Direct's pharmaceuticals report, "Galapagos NV - Product Pipeline Review - 2013" provides data on the Galapagos NV's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Galapagos NV's corporate website, SEC filings, investor presentations and featured press releases, both from Galapagos NV and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents


- Galapagos NV - Brief Galapagos NV overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Galapagos NV human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Galapagos NV with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Galapagos NV's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Galapagos NV's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Galapagos NV in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Galapagos NV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Galapagos NV.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Galapagos NV and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Ablynx NV - Product Pipeline Review - 2013
- ActogeniX NV - Product Pipeline Review - 2013
- PharmaNeuroBoost NV - Product Pipeline Review - 2013
- ThromboGenics NV - Product Pipeline Review - 2013
- TiGenix NV - Product Pipeline Review - 2013
- Apitope International NV - Product Pipeline Review - 2013
- Amakem NV - Product Pipeline Review - 2013
- Inflammatory Bowel Disease - Pipeline Review, H1 2013
- Diabetic Retinopathy - Pipeline Review, H2 2013
- Staphylococcus Aureus Infections - Pipeline Review, H2 2013